140 related articles for article (PubMed ID: 24715690)
1. Clinical relevance and therapeutic significance of microRNA-133a expression profiles and functions in malignant osteosarcoma-initiating cells.
Fujiwara T; Katsuda T; Hagiwara K; Kosaka N; Yoshioka Y; Takahashi RU; Takeshita F; Kubota D; Kondo T; Ichikawa H; Yoshida A; Kobayashi E; Kawai A; Ozaki T; Ochiya T
Stem Cells; 2014 Apr; 32(4):959-73. PubMed ID: 24715690
[TBL] [Abstract][Full Text] [Related]
2. microRNA-143 is associated with the survival of ALDH1+CD133+ osteosarcoma cells and the chemoresistance of osteosarcoma.
Zhou J; Wu S; Chen Y; Zhao J; Zhang K; Wang J; Chen S
Exp Biol Med (Maywood); 2015 Jul; 240(7):867-75. PubMed ID: 25576341
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L
Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1.
Han K; Chen X; Bian N; Ma B; Yang T; Cai C; Fan Q; Zhou Y; Zhao TB
Oncotarget; 2015 Apr; 6(11):8875-89. PubMed ID: 25823925
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z
Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921
[TBL] [Abstract][Full Text] [Related]
6. CD133(+) CD44(+) Cells Mediate in the Lung Metastasis of Osteosarcoma.
He A; Yang X; Huang Y; Feng T; Wang Y; Sun Y; Shen Z; Yao Y
J Cell Biochem; 2015 Aug; 116(8):1719-29. PubMed ID: 25736420
[TBL] [Abstract][Full Text] [Related]
7. miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo.
Duan Z; Gao Y; Shen J; Choy E; Cote G; Harmon D; Bernstein K; Lozano-Calderon S; Mankin H; Hornicek FJ
Mol Oncol; 2017 Feb; 11(2):151-166. PubMed ID: 28145098
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1.
Ji F; Zhang H; Wang Y; Li M; Xu W; Kang Y; Wang Z; Wang Z; Cheng P; Tong D; Li C; Tang H
Bone; 2013 Sep; 56(1):220-6. PubMed ID: 23756231
[TBL] [Abstract][Full Text] [Related]
9. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
Wang Z; Cai H; Lin L; Tang M; Cai H
Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients.
Song QC; Shi ZB; Zhang YT; Ji L; Wang KZ; Duan DP; Dang XQ
Oncol Rep; 2014 Mar; 31(3):1263-70. PubMed ID: 24452597
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma.
Moriya Y; Nohata N; Kinoshita T; Mutallip M; Okamoto T; Yoshida S; Suzuki M; Yoshino I; Seki N
J Hum Genet; 2012 Jan; 57(1):38-45. PubMed ID: 22089643
[TBL] [Abstract][Full Text] [Related]
12. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; Rédini F
Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
[TBL] [Abstract][Full Text] [Related]
13. miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells.
Du JY; Wang LF; Wang Q; Yu LD
Oncol Rep; 2015 Apr; 33(4):1890-8. PubMed ID: 25672572
[TBL] [Abstract][Full Text] [Related]
14. IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling.
Lu J; Song G; Tang Q; Zou C; Han F; Zhao Z; Yong B; Yin J; Xu H; Xie X; Kang T; Lam Y; Yang H; Shen J; Wang J
J Clin Invest; 2015 May; 125(5):1839-56. PubMed ID: 25822025
[TBL] [Abstract][Full Text] [Related]
15. THE INFLUENCE AND REGULATORY MECHANISM OF Y-BOX BINDING PROTEIN 1 IN OSTEOSARCOMA AND ITS SIGNIFICANCE.
Zhou WP; Liu X; Yang Y; Liu YF
J Biol Regul Homeost Agents; 2015; 29(2):485-91. PubMed ID: 26122241
[TBL] [Abstract][Full Text] [Related]
16. The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression.
Zhao M; Huang J; Gui K; Xiong M; Cai G; Xu J; Wang K; Liu D; Zhang X; Yin W
Int J Mol Med; 2014 Dec; 34(6):1565-72. PubMed ID: 25318625
[TBL] [Abstract][Full Text] [Related]
17. Regulatory effects of microRNA‑184 on osteosarcoma via the Wnt/β‑catenin signaling pathway.
Du Z; Li F; Wang L; Huang H; Xu S
Mol Med Rep; 2018 Aug; 18(2):1917-1924. PubMed ID: 29916553
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
Zou P; Ding J; Fu S
Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202
[TBL] [Abstract][Full Text] [Related]
19. GLIPR1 inhibits the proliferation and induces the differentiation of cancer-initiating cells by regulating miR-16 in osteosarcoma.
Dong J; Bi B; Zhang L; Gao K
Oncol Rep; 2016 Sep; 36(3):1585-91. PubMed ID: 27460987
[TBL] [Abstract][Full Text] [Related]
20. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.
Ma S; Tang KH; Chan YP; Lee TK; Kwan PS; Castilho A; Ng I; Man K; Wong N; To KF; Zheng BJ; Lai PB; Lo CM; Chan KW; Guan XY
Cell Stem Cell; 2010 Dec; 7(6):694-707. PubMed ID: 21112564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
